37:04Weight loss drugs patients need to make behavior changes too: Noom CEO
From the creator
This segment originally aired on October 10, 2023. Medications like Wegovy and Ozempic, both made by Novo Nordisk (NVO), have taken the U.S. by storm thanks to their ability to help people lose weight. But if patients want to keep the weight off, they need to make some behavioral changes too, Noom CEO Geoff Cook explains to Yahoo Finance's Anjalee Khemlani at the 2023 HLTH Conference. Cook says that these drugs are "extremely effective, but unless they're paired with behavior change, you're on them forever, right? And I think most people don't want to have a forever drug, especially one that's quite expensive and comes with side effects." Noom recently announced a new offering called Noom Med for Enterprise to help patients on these drugs ween off of them and keep the weight off. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Yahoo Finance Plus: With a subscription to Yahoo Finance Plus get the tools you need to invest with confidence. Discover new opportunities with expert research and investment ideas backed by technical and fundamental analysis. Optimize your trades with advanced portfolio insights, fundamental analysis, enhanced char
Published 2023-10-14 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.





